Research & Development · Product Development · Contract Research
Life-sciences R&D and product development — start with a defined scientific question.
Manna Biotech Pvt. Ltd. is a founder-led research organisation in Hyderabad, India. We partner with pharma, nutraceutical, biotech and startup clients — from discovery and assay development through sequencing, molecular characterisation and data analysis — and we advance our own internal R&D.
Every engagement is scoped under a written proposal. An NDA is available before any detailed discussion, and data access, ownership and intellectual-property terms require a written agreement.
Plan your project
Choose the next R&D decision before choosing a method
Pharma, nutraceutical, agri-biotech and life-science product teams often need different evidence at different stages. Start with the decision a study should inform: whether to continue an idea, improve a method, compare candidates or prepare a defined handover. Then scope the work required to support it.
Decision 1
Separate exploration from a decision-ready comparison
An exploratory screen can reveal whether a question is worth pursuing. A candidate comparison needs a pre-agreed endpoint, appropriate comparator and a plan for variation between samples or runs. State the decision rule and the uncertainty you can tolerate before reviewing results, rather than choosing a favourable endpoint afterwards.
Decision 2
Distinguish method development from routine testing
A method-development request should identify the sample matrix, target measurement, existing protocol and unresolved performance questions. Routine testing assumes a suitable method already exists. If development is still needed, separate feasibility and optimisation from the later sample batch so that costs, repeats and acceptance criteria can be discussed honestly.
Decision 3
Match the evidence to its intended use
For a pharma or nutraceutical project, explain whether the output supports internal discovery, research documentation or a regulated decision. A research-stage result does not automatically establish clinical benefit, product safety, statutory compliance or release suitability. Any specialist or regulated work needs separately confirmed execution capability and reporting requirements.
Use a staged proposal with explicit decision points
A useful proposal separates feasibility, agreed execution and interpretation. For each stage, identify required inputs, a deliverable, a review owner and the condition for proceeding. Record how failed quality checks, revised methods or extra samples would change the scope before they create unexpected work.
What we do
Scientific capability, end to end.
Discovery & early research
Target identification, proof-of-concept assays, literature due diligence and feasibility studies.
Research-use assay development
PCR and qPCR assay design, optimisation and analytical assessment for defined research and industry questions.
Biomarker discovery & validation
Feasible genomic, expression and molecular biomarker work that connects candidate selection, assay design, data analysis and research-use validation.
Genomics & sequencing
Sequencing and existing-data analysis questions, with platform, execution route, quality checks and analysis deliverables requiring confirmation.
In-vitro & molecular validation
Proposed cell-culture, microbiology or molecular endpoints, with model, method, execution route and analysis scope requiring confirmation.
Microbial & probiotic science
16S and whole-genome profiling of probiotic strains, contamination profiling and microbial community analysis.
Nutraceutical & plant science
Plant DNA barcoding, adulteration detection and molecular authentication for the herbal and nutraceutical sector.
Patent & IP documentation
Prior-art screening, invention disclosures and technical drafting, coordinated with registered patent professionals.
Product development
From an idea to a validated method.
We develop assays, methods and molecular products with our clients — designing the protocol, running the science, validating the result and handing over transfer documentation your team can actually use. Where an outcome is patentable, our patent & IP documentation support helps you capture it properly, coordinated with registered patent professionals.
Alongside client programs, Manna Biotech advances its own internal R&D and intellectual property. Details of our in-house work are shared under NDA with serious partners and investors.
We are a research organisation, not a law firm — we do not file patents directly, and no one can guarantee a patent grant, a publication or a regulatory outcome.
How we engage
Discovery engagement
A short, scoped study — proof of concept, feasibility or due diligence — with defined endpoints and timelines.
Method development
Assay or pipeline development, delivered with validation and transfer documentation.
Multi-phase program
A long-running research partnership under a master services agreement (MSA).
Recurring R&D retainer
An agreed monthly or batch-based scope for repeat testing, analysis, method support or product-development work.
Why partner with Manna Biotech
Founder-led research, with execution responsibilities defined upfront.
Founder-led by a scientist
Dr Chathyushya K B leads Manna Biotech. The scientific reviewer, relevant expertise and execution responsibilities for a proposed project must be confirmed during scope review.
Confirm the execution route
Before acceptance, confirm the named facility, instruments, personnel, method and availability for each proposed work package. A service topic alone does not establish in-house execution.
A registered scientific company
Manna Biotech Pvt. Ltd. — CIN U73100TG2021PTC151489, GSTIN 36AAOCM5975F1ZX. Current methods, delivery scope and any partner or regulatory requirement are confirmed before quotation.
Documented, transparent delivery
Projects run to defined SOPs with agreed endpoints, timelines and deliverables set before kick-off, and full data transparency throughout.
Agree data and IP terms
Request confidentiality arrangements before sharing detailed information. Data access, deliverable ownership, permitted use and IP terms require agreement before work begins.
A talent pipeline built in
Our training and project ecosystem means scientists we have personally trained — a practical advantage when a program needs to scale.
Investors & strategic partners
Building a life-sciences R&D company from Hyderabad.
Research proposals need defined questions, methods, execution responsibilities and evidence that can be reviewed. We are open to conversations with investors and strategic partners who want to build life-sciences R&D and product development capability in India.
Our capability, facility, in-house R&D direction and commercial detail are discussed directly with the founders under NDA — not published on a web page.
The wider Manna Biotech ecosystem
Our R&D sits alongside a hands-on training, project and PhD ecosystem.
Start a conversation
Tell us what you need researched.
Share a short outline of your requirement — we will come back with the right scientist, a scoped approach and next steps. An NDA can be signed before any detailed discussion.
Related services
Move from a research objective to the right delivery path.
CRO / contract research
Move to a formal client-research engagement with defined milestones, deliverables and NDA-based scoping.
Molecular testing & diagnostics
Request a defined testing service for PCR, sequencing, microbial identification, authenticity or diagnostics work.
In-vitro research services
Review current cell-culture, microbiology and molecular endpoints, with model and method feasibility confirmed before quotation.
Bioinformatics & NGS analysis
Connect sequencing or existing data to reproducible analysis, publication-ready figures and scientist interpretation. Discuss molecular docking or dynamics scope for suitable in-silico research questions.
Research feasibility review
Start with samples, methods, endpoints, compliance needs, timeline and deliverables before choosing a service path.
Patent data & technical support
Connect research output to prior-art, patent landscape and experimental evidence for a life-science innovation.
Preclinical feasibility review
Review a proposed animal study only after the external executing facility, ethics, permissions and responsibilities can be verified.
Molecular assay scoping
Discuss research-use PCR or qPCR targets, sample requirements and agreed endpoints for a defined R&D question.
Questions
Frequently asked questions
What kind of research can Manna Biotech take on?
+
Feasibility and early research; research-use PCR and qPCR assay development; Oxford Nanopore workflow requirements; analysis of suitable external sequencing data; microbial and probiotic profiling; nutraceutical and plant science including DNA barcoding and molecular authentication; and patent/IP documentation support. Final acceptance depends on scope, samples, intended use and current capability.
Who owns the intellectual property from a project?
+
Data and intellectual-property rights must be agreed in writing, including pre-existing materials, project outputs, permitted use and contributor or institutional rights. Request confidentiality terms before sharing detailed information.
How does an engagement start?
+
With a scoping conversation, followed by a written proposal setting out the approach, endpoints, timelines and deliverables before any work begins. Engagements run as a short discovery study, a method-development project, or a multi-phase programme under a master services agreement.
Do you work with early-stage startups as well as established companies?
+
Yes. Short scoped studies suit startups that need proof of concept, feasibility or due diligence without committing to a long programme, and can scale into a longer partnership if the science justifies it.
Can Manna Biotech support recurring testing or R&D work?
+
Yes, when the method and sample flow are feasible. A retainer can define the recurring scope, batch or monthly cadence, reporting format, turnaround expectations and named scientific contact without publishing arbitrary fixed pricing.
Are in-vivo, toxicology or regulated analytical services included?
+
Not as blanket current capability. These requirements proceed only after the facility, approvals, method scope, execution responsibility and reporting route are separately verified. Manna Biotech does not imply ownership of an animal facility or unsupported accreditation.
What makes Manna Biotech different from a pure service laboratory?
+
Manna Biotech is founder-led by Dr Chathyushya K B. For a proposed engagement, request the specific scientific reviewer, execution location, methods, quality checks and reporting responsibilities. This page does not establish ownership of equipment or approval of every listed workflow.
Are you open to investor or strategic partnership conversations?
+
Yes. Our capability, facility, in-house R&D direction and commercial detail are discussed directly with the founders under NDA rather than published. Partnerships and business enquiries go to S. Rupas Kumar on +91 8977681985.
What should I include in an R&D feasibility brief?
+
Outline the research question or development decision, the material or existing data and approximate scale, previous work and available controls, the outputs needed to assess the next step, desired milestones, and unresolved feasibility constraints. Identify any required permissions, biosafety review or reporting standard without assuming it is covered. A short non-confidential description is enough for the first enquiry; sensitive formulations or intellectual property can be discussed through an agreed process. A requested method or date remains subject to scope review.